Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regros with or without KM R-Fit in flap surgery for periodontitis
jRCTs061250060Recruiting
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of regorafenib and KM R-Fit in periodontitis (2 arms). Primary endpoint: Primary safety endpoint. Started Oct 2025; status: recruiting.
02
Drugs
regorafenibKM R-Fit
03
Conditions
periodontitis
Beyond the preview
Go deeper on jRCTs061250060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061250060.